Alberta Investment Management Corp Meridian Bioscience Inc Transaction History

Alberta Investment Management Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $544,258 - $749,436	-34,600 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$7.84 - $23.29 $271,264 - $805,834	34,600 New	34,600 $806,000
Q1 2020 May 08, 2020	SELL	$5.57 - $11.5 $83,550 - $172,500	-15,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.9 - $10.14 $182,490 - $234,234	-23,100 Reduced 60.63%	15,000 $147,000
Q3 2019 Oct 23, 2019	BUY	$9.17 - $12.01 $349,377 - $457,581	38,100 New	38,100 $362,000
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $224,128 - $362,560	-20,600 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $279,180 - $316,980	-18,000 Reduced 46.63%	20,600 $363,000
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $159,720 - $216,920	-11,000 Reduced 22.18%	38,600 $670,000
Q3 2018 Nov 16, 2018	SELL	$14.85 - $16.35 $524,205 - $577,155	-35,300 Reduced 41.58%	49,600 $739,000
Q2 2018 Aug 15, 2018	BUY	$13.8 - $16.8 $735,540 - $895,440	53,300 Added 168.67%	84,900 $1.35 Million
Q1 2018 May 16, 2018	BUY	$13.8 - $16.2 $436,080 - $511,920	31,600 New	31,600 $449,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.